Tuesday, June 6, 2017

Drug Prices Become Target for FDA as Chief Expands Purview

Drug Prices Become Target for FDA as Chief Expands Purview-bloomberg: The head of the U.S. Food and Drug Administration is considering using the agency’s powers to bring more price competition to the market for generic drugs, targeting high-priced products by prioritizing the approval of additional competing treatments.